Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.7 |